**Background**
Glycogen synthase kinase-3 beta (GSK-3β) is a multifunctional serine/threonine kinase that plays a critical role in various cellular processes, including metabolism, signal transduction, and cell proliferation. One of its most prominent roles is the negative regulation of the Wnt signaling pathway, where it facilitates the degradation of β-catenin. In the context of endocrine health, the expansion and proliferation of pancreatic beta cells are essential for maintaining glucose homeostasis and treating metabolic disorders such as diabetes. Because GSK-3β acts as a brake on beta-cell proliferation, its inhibition represents a promising therapeutic strategy to stimulate the regeneration of insulin-producing cells. In this context, we will introduce a selective GSK-3β inhibitor – GSK-3β inhibitor 8.
**Definition**
GSK-3β inhibitor 8 is a thiophenacil derivative that serves as an effective and selective inhibitor of GSK-3β, exhibiting an IC50 value of 64 nM.
**In Vitro Studies**
According to the GSK-3β inhibitor 8 description, this compound negatively regulates the Wnt signaling pathway to stimulate the proliferation of beta cells. In terms of GSK-3β inhibitor 8 in vitro activity, studies demonstrated that the compound (1 nM-100 μM; 7 d) stimulates β-cell proliferation in a dose-dependent manner with an EC50 value of 1.41 μM. Furthermore, treatment with GSK-3β inhibitor 8 (2 μM; 72 h) was found to increase the replication of R7T1 β cells approximately 2-fold. The compound also induces the activation of the Super (8X) TOPFlash reporter (1 nM-100 μM; 24 h) with an EC50 value of 1.25 μM. Additionally, GSK-3β inhibitor 8 (2 μM; 72 h) stimulates the translocation of β-catenin into the nucleus in HEK293 cells, confirming its role in activating the Wnt pathway. For researchers requiring specific GSK-3β inhibitor 8 technical information regarding its chemical properties, the compound has a molecular weight of 413.92 and a molecular formula of C20H20ClN5OS. In conclusion, GSK-3β inhibitor 8 is a potent thiophenacil derivative that promotes pancreatic beta-cell expansion through the inhibition of GSK-3β and the subsequent activation of the Wnt/β-catenin signaling pathway.
Keywords
GSK-3β inhibitor 8, 1139875-74-3, Wnt, GSK-3, Glycogen synthase kinase-3, Glycogen synthase kinase 3, Inhibitor, inhibitor, inhibit
References